Skip to content

Erosive Esophagitis

NO LONGER ACCEPTING APPLICATIONS
Published on:
September 18, 2024
Sign-up Expiration:
Updated:
Topics:
Locations:

The first phase (Healing Phase) consists of a Screening Period of up to 28 days, a Treatment Period of up to 8 weeks, and a Follow-Up Contact 14 days after the last dose of study drug for patients who do not move to the Maintenance Phase. The second phase (Maintenance Phase) consists of a Treatment Period of 24 weeks and a Follow-Up Contact 14 days after the last dose of study drug.

View Additional Information
View Clinical Trial Attachment
Sign Up NowExpired - View Other Trials
ENDED